Metalloreductase STEAP1 (292-300)

Metalloreductase STEAP1 (292-300) is a synthetic peptide fragment derived from the C-terminal region of the Six-Transmembrane Epithelial Antigen of the Prostate 1 (STEAP1) protein. As part of the STEAP family, STEAP1 is recognized for its role in metal ion reduction and cellular homeostasis, particularly in the context of iron and copper metabolism. The 292-300 peptide sequence represents a specific epitope within the broader protein structure, making it a valuable tool for probing protein function, mapping molecular interactions, and supporting targeted biochemical studies. Its defined sequence and origin facilitate precise investigations into the structural and functional properties of STEAP1, which is increasingly relevant in both fundamental research and specialized application areas.

Epitope mapping: The STEAP1 (292-300) peptide serves as an essential reagent for epitope mapping studies, enabling researchers to identify and characterize antibody binding sites within the STEAP1 protein. By immobilizing or conjugating this peptide, scientists can assess the specificity and affinity of antibodies generated against STEAP1, supporting the development of high-fidelity immunoassays or the refinement of antibody-based detection methods. Such mapping is crucial for validating the selectivity of immunological reagents and for advancing the understanding of STEAP1's immunogenic domains.

Antibody production and validation: As an immunogenic peptide fragment, the 292-300 sequence is employed in the generation of polyclonal or monoclonal antibodies targeting STEAP1. Its defined structure allows for the production of antibodies with high specificity to the C-terminal region, which can be utilized in various immunodetection techniques, including Western blotting, immunohistochemistry, and ELISA. The peptide also provides a reliable standard for validating antibody performance, ensuring reproducibility and accuracy in downstream applications.

Protein-protein interaction studies: The STEAP1 (292-300) peptide is instrumental in delineating protein-protein interactions involving the STEAP1 protein. By acting as a molecular probe or competitive inhibitor, the peptide can help elucidate binding partners and interaction motifs relevant to STEAP1's biological roles. Such studies are integral to understanding the mechanistic underpinnings of metal ion transport, cellular signaling pathways, and the broader functional context of STEAP family members.

Peptide-based assay development: Incorporation of the 292-300 fragment into customized assay platforms allows for the quantitative and qualitative assessment of STEAP1-related activities. The peptide can be used as a calibrator, substrate, or capture agent in enzyme-linked assays, biosensors, or multiplexed detection systems. Its sequence specificity supports the creation of robust and sensitive assays tailored to the study of STEAP1 expression, post-translational modifications, or interaction dynamics.

Structure-function analysis: The defined amino acid sequence of the STEAP1 (292-300) peptide provides a foundation for investigating the structural determinants of STEAP1's activity. By subjecting the peptide to biophysical characterization techniques such as circular dichroism, NMR spectroscopy, or computational modeling, researchers can gain insights into secondary structure, conformational stability, and functional motifs. These analyses contribute to a deeper understanding of how specific regions within STEAP1 influence its metalloreductase activity and broader cellular functions.

Overall, the STEAP1 (292-300) peptide offers a versatile platform for advancing peptide research, supporting a range of applications from immunological studies to molecular interaction analysis and assay development. Its targeted sequence and biochemical relevance make it an indispensable tool for researchers exploring the functional landscape of STEAP1 and related metalloreductase proteins.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

3. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

4. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

5. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries